PLOS ONE study finds that severe burns dramatically alter bacteria populationsA study published in PLOS ONE has found that burn patients experience dramatic changes in the 100 trillion bacteria...
Mutations in a key autoimmunity-associated gene are surprisingly common and are responsible for a previously unknown form of a rare autoimmune disorder called APS-1, according to a study published on...
MSD (known as Merck & Co., Inc. in the US and Canada) has announced the availability in the UK of Sivextro® (tedizolid phosphate) for the treatment of acute bacterial skin and skin structure...
Micreos, a Dutch biotech company, presented data on the potential use of endolysins as an alternative to antibiotics at the Royal Society of Medicine (RSM) Medical Innovations Spring Summit.
Bioplastics show promise in search for antibacterial packagingBioplastics made from protein sources such as albumin and whey have shown significant antibacterial properties, findings that could...
Use of clinical, genomic factors to identify those at risk for multiple infections could improve treatment outcomes, reduce antibiotic resistanceA team led by Massachusetts General Hospital (MGH)...
A team of international scientists has discovered a new mechanism by which immune cells in the skin function as the body's 'border control', revealing how these cells sense whether lipid or fat-like...
A team of Massachusetts General Hospital (MGH) investigators has identified what may be a biomarker predicting the development of the dangerous systemic infection sepsis in patients with serious...